Cost effectiveness of MF59 adjuvanted influenza vaccine in France

被引：0
|
作者：
Chambers, J.
Eijgelshoven, I
Piercy, J.
Wait, S.
机构：
[1] Mapi Values, Boston, MA USA
[2] Mapi Values, Houten, Netherlands
[3] Phimap, Bollington, England
[4] SHW Hlth, London, England
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)69036-5
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
下载
收藏
页码：A163 / A164
页数：2
相关论文
共 50 条
  • [11] Comparison of the safety and immunogenicity of an MF59®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects
    Frey, Sharon E.
    Aplasca-De Los Reyes, Mari Rose
    Reynales, Humberto
    Bermal, Nancy Nazaire
    Nicolay, Uwe
    Narasimhan, Vas
    Forleo-Neto, Eduardo
    Arora, Ashwani Kumar
    VACCINE, 2014, 32 (39) : 5027 - 5034
  • [12] Effectiveness of MF59™-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly
    Puig-Barbera, Joan
    Diez-Domingo, Javier
    Belenguer Varea, Angel
    Schwarz Chavarri, German
    Lluch Rodrigo, Jose A.
    Perez Hoyos, Santiago
    Gonzalez Vidal, David
    VACCINE, 2007, 25 (42) : 7313 - 7321
  • [13] Relative Effectiveness of MF59 Adjuvanted Trivalent Influenza Vaccine vs Nonadjuvanted Vaccines During the 2019-2020 Influenza Season
    Imran, Mahrukh
    Puig-Barbera, Joan
    Ortiz, Justin R.
    Fischer, Lauren
    O'Brien, Dan
    Bonafede, Machaon
    Mansi, James A.
    Boikos, Constantina
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (05):
  • [14] Influenza A/H1N1 MF59 adjuvanted vaccine safe during pregnancy
    Reactions Weekly, 2013, 1441 (1) : 3 - 3
  • [15] Novartis MF59®-adjuvanted influenza vaccine booster could provide protection within days of injection
    不详
    EXPERT REVIEW OF VACCINES, 2008, 7 (09) : 1305 - 1305
  • [16] Cost-effectiveness of introducing an MF59-adjuvanted trivalent influenza vaccine for older adults in Argentina
    Van Hung Nguyen
    Vizzotti, Carla
    Uruena, Analia
    Giglio, Norberto
    Magneres, Cecilia
    Richmond, Heather
    VACCINE, 2020, 38 (20) : 3682 - 3689
  • [17] Effectiveness of MF59™ Adjuvanted Influenza A(H1N1)pdm09 Vaccine in Risk Groups in the Netherlands
    Wijnans, Leonoor
    Dieleman, Jeanne
    Voordouw, Bettie
    Sturkenboom, Miriam
    PLOS ONE, 2013, 8 (04):
  • [18] MF59®-adjuvanted influenza vaccine (FLUAD®) in children: Safety and immunogenicity following a second year seasonal vaccination
    Vesikari, T.
    Groth, N.
    Karvonen, A.
    Borkowski, A.
    Pellegrini, M.
    VACCINE, 2009, 27 (45) : 6291 - 6295
  • [19] Relative Effectiveness of the MF59®-Adjuvanted Influenza Vaccine Versus High-Dose and Non-Adjuvanted Influenza Vaccines in Preventing Cardiorespiratory Hospitalizations During the 2019-2020 US Influenza Season
    Imran, Mahrukh
    Puig-Barbera, Joan
    Ortiz, Justin R.
    Lopez-Gonzalez, Lorena
    Dean, Alex
    Bonafede, Machaon
    Haag, Mendel D. M.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2024, 18 (04)
  • [20] The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine
    Podda, A
    VACCINE, 2001, 19 (17-19) : 2673 - 2680
12345